R. Floyd
Plus aucun poste en cours
Profil
R.
Michael Floyd was the founder of Elion Oncology, Inc. which was founded in 2016, where he held the titles of President, Chief Executive Officer & Director.
Mr. Floyd is also the founder of BioAim LLC, Exbaq LLC.
He previously worked as the Chief Executive Officer-North America at Evolva Holding SA. He also worked as the Chief Operating Officer at Processa Pharmaceuticals, Inc. from 2020 to 2023.
Mr. Floyd obtained his undergraduate degree from Georgetown University.
Anciens postes connus de R. Floyd
Sociétés | Poste | Fin |
---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Chief Operating Officer | 31/08/2023 |
BioAim LLC | Founder | - |
Exbaq LLC | Founder | - |
EVOLVA HOLDING SA | Corporate Officer/Principal | - |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Elion Oncology, Inc. engages in the provision of pharmaceutical services. The company was founded in 2016 and is headquartered in Bethesda, MD. | Founder | - |
Formation de R. Floyd
Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
EVOLVA HOLDING SA | Consumer Non-Durables |
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Elion Oncology, Inc. engages in the provision of pharmaceutical services. The company was founded in 2016 and is headquartered in Bethesda, MD. | Health Technology |
BioAim LLC | |
Exbaq LLC |